Share ownership bioMérieux

BIM

FR0013280286

Medical Equipment, Supplies & Distribution

Real-time Euronext Paris Other stock markets 15:32:59 10/09/2024 BST			5-day change	1st Jan Change
109.60 ^EUR	-0.63%		+7.14%	+8.95%

09-09	The market burns its idols
09-06	BIOMÉRIEUX : Invest Securities raises its target	CF

Share class: bioMérieux

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	118,361,220	42,884,157 ( 36.23 %)	431,868 ( 0.3649 %)	36.23 %

Major shareholders: bioMérieux

Name	Equities	%	Valuation
Compagnie Merieux Alliance SAS 58.90 %	69,720,270	58.90 %	8 080 M €
Dassault Family 3.796 %	4,493,520	3.796 %	521 M €
Sofina SA (Private Equity) 1.928 %	2,282,513	1.928 %	265 M €
Oddo BHF Asset Management SAS 1.256 %	1,486,843	1.256 %	172 M €
bioMérieux SA Employee Stock Ownership Plan 0.8359 %	989,348	0.8359 %	115 M €
Eleva Capital SAS 0.2820 %	333,732	0.2820 %	39 M €
Crédit Mutuel Asset Management SA 0.2626 %	310,789	0.2626 %	36 M €
Devon Equity Management Ltd. 0.2404 %	284,562	0.2404 %	33 M €
FIL Gestion SASU 0.2396 %	283,638	0.2396 %	33 M €
Zadig Asset Management LLP 0.2387 %	282,500	0.2387 %	33 M €
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Other	59.74%
Institutional	6.77%
Individuals	3.80%
bioMérieux SA	0.17%
Unknown	29.52%

Based on 1000 largest holdings

Geographical origin of shareholders

France	63.04%
Individuals	3.80%
Belgium	1.93%
United Kingdom	0.61%
Germany	0.30%
Spain	0.15%
Luxembourg	0.14%
Italy	0.12%
Norway	0.09%
Finland	0.08%
Sweden	0.08%
Netherlands	0.04%
Ireland	0.03%
Switzerland	0.02%
Japan	0.01%
Slovenia	0.01%
Denmark	0.01%
Austria	0.01%
Liechtenstein	0.01%

Based on 1000 largest holdings

bioMérieux designs, develops, produces, and sells systems used in clinical practice to diagnose infectious diseases (including HIV, tuberculosis, and respiratory infections), cancers, and cardiovascular pathologies based on a biological sample (blood, saliva, urine, etc.). Net sales break down by sector of application as follows: - medical applications (84.4%): in industry, microbiological testing of samples from finished products, materials during the manufacturing process, or the environment, primarily in the food-processing, pharmaceutical, and cosmetics sectors; - industrial applications (15.6%). The group's diagnostic systems consist of three elements with related services: reagents, instruments (or platforms or analyzers), software, and services. Net sales are distributed geographically as follows: Europe/Middle East/Africa (32.4%), North America (44.1), Asia/Pacific (17.3%) and Latin America (6.2%).

Employees

13,696

Sector

Medical Equipment, Supplies & Distribution

Calendar

29/10/2024 - Q3 2024 Sales and Revenue Call

Related indices

STOXX Europe 600 Index (EUR)

More about the company